In this image made available by NASA, the Mars Ingenuity helicopter hovers above the surface of the planet during its second flight on Thursday, April 22, 2021. (NASA/JPL-Caltech/ASU/MSSS via AP)
By Marcia Dunn
NASA’s little Mars helicopter aced its second test flight Thursday, soaring even higher and longer than before.
The 4-pound (1.8-kilogram) chopper, named Ingenuity, hovered longer and also flew side to side this time, according to NASA's Jet Propulsion Laboratory in California. It achieved the intended altitude of 16 feet (5 meters) and even accelerated sideways 7 feet (2 meters).
This hop lasted 52 seconds, 13 seconds longer than the first one.
“Go big or go home!” JPL tweeted in announcing the Earth Day news.
The success came just three days after Ingenuity made the first powered flight by an aircraft on another planet. The helicopter carried a bit of wing fabric from the Wright Flyer that made similar history at Kitty Hawk, North Carolina, in 1903.
Flight controllers had to wait four hours before learning Thursday's outcome. Like it did during Monday's 10-foot-high (3-meter-high) hop, the helicopter sent back a black and white photo showing its shadow against the dusty, rock-strewn surface now known as Wright Brothers Field.
“It sounds simple, but there are many unknowns regarding how to fly a helicopter on Mars," Ingenuity’s chief pilot, Havard Grip, said from JPL in a statement. “That’s why we’re here — to make these unknowns known.”
One of the challenges is the planet’s extremely thin atmosphere — 1% that of Earth's.
NASA plans up to three more test flights in the next 1 1/2 weeks, venturing higher each time with more complicated acrobatics. Ingenuity hitched a ride to Mars on the rover Perseverance, which photographed the proceedings from more than 200 feet (64 meters) away. The rover team allotted one month for the $85 million tech demo; The clock started ticking when Ingenuity was released from Perseverance's belly on April 3.
“We have two flights of Mars under our belts, which means that there is still a lot to learn during this month of Ingenuity," chief engineer Bob Balaram said in a statement.
Perseverance and Ingenuity arrived at Mars in mid-February, landing in an ancient river delta following a 6 1/2-month flight.
Once Ingenuity's flights are complete, Perseverance will set off on its journey to find any signs of past microscopic life. A robotic geologist, the rover will collect core samples of the most enticing rocks and set them aside for pickup by a future spacecraft a decade from now.
In another first, an experiment on the rover successfully converted Mars’ carbon-dioxide-rich atmosphere into pure oxygen this week. Five grams of oxygen was produced, according to NASA, the equivalent of 10 minutes of breathing for an astronaut. Large-scale production at Mars could yield oxygen not only for air, but also rocket fuel. More tests are planned over the next two years.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
